Pcv (Pneumococcal Conjugate Vaccine) Suppliers & Bulk Manufacturers
Available Forms: Vial doses, Pre-filled syringes
Available Strengths: 0.5 mL
Reference Brands: Prevnar 13(US)
Category: Vaccines
PCV (Pneumococcal Conjugate Vaccine) stimulates immunity by introducing polysaccharides linked to proteins, prompting the body to produce antibodies against pneumococcal bacteria. It prevents pneumonia, meningitis, and bacteremia, reducing illness, hospitalizations, and death, especially in children, supporting lifelong protection and community health. PCV (Pneumococcal Conjugate Vaccine) is available in Vial doses, Pre-filled syringes and strengths such as 0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, PCV (Pneumococcal Conjugate Vaccine) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
PCV (Pneumococcal Conjugate Vaccine) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
PCV (Pneumococcal Conjugate Vaccine) is approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval requires comprehensive clinical data; in the EU, CE marking certifies conformity with in vitro diagnostic and medicinal regulations. These vaccines undergo validation, stability testing, and extensive audits, with detailed documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective pneumococcal vaccines for global immunization efforts reducing pneumonia, meningitis, and sepsis.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Pneumococcal Conjugate Vaccine (PCV) is used to protect against infections caused by the bacterium Streptococcus pneumoniae. It helps prevent serious diseases such as pneumonia, meningitis, and bacteremia, especially in infants, young children, the elderly, and individuals with weakened immune systems.
PCV is made from purified capsular polysaccharides of different serotypes of Streptococcus pneumoniae, which are chemically linked (conjugated) to a carrier protein, typically a non-toxic diphtheria CRM197 protein. This conjugation enhances the immune response, especially in young children.
The trade names for PCV include Prevnar 13, Vaxneuvance, and Synflorix.
Prevnar 13 is manufactured by Pfizer Inc., Vaxneuvance is made by Merck & Co., and Synflorix is produced by GlaxoSmithKline (GSK).
The generic name of this product is Pneumococcal Conjugate Vaccine.
The brand names of this vaccine are Prevnar 13, Vaxneuvance, and Synflorix.
Pneumococcal Conjugate Vaccine is manufactured in various locations globally depending on the brand. Pfizer manufactures Prevnar 13 in the United States and Belgium, Merck produces Vaxneuvance in the United States, and GSK manufactures Synflorix in Belgium.
Related Products
Respiratory Syncytial Virus Mrna Vaccine
Strength:
0.5 mL
Form: injection (prefilled syringe)
Reference Brands: mRESVIA (USA/EU)
View Details
Inactivated Vaccines
Strength:
Dose and concentration depend on formulations
Form: Injectable suspension (IM administration), Lyophilized powder for reconstitution
Reference Brands: Sinovac Coronavac. Covaxin(EU)
View Details
Viral Vector Vaccines
Strength:
0.5 mL
Form: Intramuscular injectable suspension (IM)
Reference Brands: US: Johnson & Johnson’s Janssen (Jcovden)
View Details
Mrna-Based Vaccines
Strength:
30 µg and 100 µg
Form: Injectable suspension
Reference Brands: Comirnaty, Spikevax(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
